NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2025
Voltar para busca
Dado oficial do USPTO
POWERED BY BIOHM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
POWERED BY BIOHM
ST13
US500000097008640Classe
5
Pedido
97008640
Registro
8061014
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
09/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
02/09/2021
Data de registro
09/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/12/2025
Última transação
09/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
31/12/2021
Primeiro uso no comércio
31/12/2021
Código do desenho
4
Tipo de titular
03
Localização do titular
CLEVELAND, OH, US
Examinador
REINHART,MEGHAN M
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BIOHM HEALTH INC.
Biohm Health LLC
Representantes
Lisa C. Pavento Meunier Carlin & Curfman LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplementsprobiotic compositions; nutritional supplementscarbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powdertabletliquidcapsule or spray form; mineral supplements in powdertabletliquidcapsule or spray form; dietary supplements in powdertabletliquidcapsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powdertabletliquidcapsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powdertabletliquidcapsule or spray form; herbal supplements for general health and well-beingin powdertabletliquidcapsule or spray form; nutritional supplementsprobiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosisvaginal discharge and odorsfor preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odorkilling bacteria that cause bacterial vaginosisfor maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical uselactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's Disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's Disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical productsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's Disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements containing microorganisms and cultures of microorganismsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibers in the human organism; pharmaceutical products for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and Crohn's Disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical useprobioticsfor improving the physical well-being of humansreducing inflammation and pain; dietary supplements for medical use and baby food containing microorganismsmetabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal extracts sold as a component ingredient of nutritional supplments and vitamins and bacterial probiotic supplementsnutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Diseaseulcerative colitis and irritable bowel syndrome; beverages containing probiotic compositions for use as a nutritional supplement; food supplements containing probiotic compositions; human food supplements containing probiotic compositions; animal food products containing probiotic compositionsprobiotic animal feed; dietary supplement drink mixesprobiotic compositions in the form of mixes to added to beverages; dietary supplements in the nature of probiotic compositions for mixing with cereal; medical specimens collection kits for the collection of body fluids comprised of swabs for medical purposesa sealable collection container and sample bag; medical specimens collection kits for the collection of body fluids comprised of swabs for medical purposesa sealable collection containersample bagmailer envelopeID stickerswab applicator; diagnostic biological testing kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; diagnostic genetic testing kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; diagnostic microbiota testing kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; medical specimen collection kits for the collection of body fluids comprised of medical specimen bags and cups
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
17/11/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
17/11/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
17/11/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/11/2025
DOCK
ASSIGNED TO EXAMINER
23/10/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/10/2025
IUAF
USE AMENDMENT FILED
11/04/2025
EISU
TEAS STATEMENT OF USE RECEIVED
11/04/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/10/2024
EX4G
SOU EXTENSION 4 GRANTED
24/10/2024
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
14/10/2024
NREV
NOTICE OF REVIVAL - E-MAILED
14/10/2024
PETG
PETITION TO REVIVE-GRANTED
14/10/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
14/10/2024
EXT4
SOU EXTENSION 4 FILED
11/10/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/04/2024
EX3G
SOU EXTENSION 3 GRANTED
09/04/2024
EXT3
SOU EXTENSION 3 FILED
09/04/2024
EEXT
SOU TEAS EXTENSION RECEIVED
09/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/10/2023
EX2G
SOU EXTENSION 2 GRANTED
11/10/2023
EXT2
SOU EXTENSION 2 FILED
11/10/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/04/2023
EX1G
SOU EXTENSION 1 GRANTED
20/04/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
19/04/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/04/2023
EXT1
SOU EXTENSION 1 FILED
07/04/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/04/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/08/2022
PUBO
PUBLISHED FOR OPPOSITION
16/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/07/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/01/2022
GNRT
NON-FINAL ACTION E-MAILED
12/01/2022
CNRT
NON-FINAL ACTION WRITTEN
12/01/2022
DOCK
ASSIGNED TO EXAMINER
10/01/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace POWERED BY BIOHM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.